Actinogen Medical Limited (ATGGF)
OTCMKTS · Delayed Price · Currency is USD
0.0250
+0.0010 (4.17%)
Sep 12, 2025, 12:39 PM EDT

Actinogen Medical Statistics

Total Valuation

ATGGF has a market cap or net worth of 56.89 million. The enterprise value is 48.10 million.

Market Cap56.89M
Enterprise Value 48.10M

Important Dates

The last earnings date was Thursday, August 28, 2025.

Earnings Date Aug 28, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class 3.18B
Shares Outstanding n/a
Shares Change (YoY) +37.04%
Shares Change (QoQ) +4.26%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 2.49B

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 15.81
PB Ratio 4.73
P/TBV Ratio 5.24
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -4.98
EV / Sales 13.21
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -9.66

Financial Position

The company has a current ratio of 3.76, with a Debt / Equity ratio of 0.18.

Current Ratio 3.76
Quick Ratio 3.74
Debt / Equity 0.18
Debt / EBITDA n/a
Debt / FCF -0.43
Interest Coverage -314.05

Financial Efficiency

Return on equity (ROE) is -77.47% and return on invested capital (ROIC) is -46.12%.

Return on Equity (ROE) -77.47%
Return on Assets (ROA) -41.91%
Return on Invested Capital (ROIC) -46.12%
Return on Capital Employed (ROCE) -82.89%
Revenue Per Employee 599,838
Profits Per Employee -1.61M
Employee Count 6
Asset Turnover 0.24
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +66.67% in the last 52 weeks. The beta is 1.06, so ATGGF's price volatility has been similar to the market average.

Beta (5Y) 1.06
52-Week Price Change +66.67%
50-Day Moving Average 0.02
200-Day Moving Average 0.02
Relative Strength Index (RSI) 54.51
Average Volume (20 Days) 4,875

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, ATGGF had revenue of 3.60 million and -9.66 million in losses. Loss per share was -0.00.

Revenue3.60M
Gross Profit 3.60M
Operating Income -10.07M
Pretax Income -9.66M
Net Income -9.66M
EBITDA -9.84M
EBIT -10.07M
Loss Per Share -0.00
Full Income Statement

Balance Sheet

The company has 10.82 million in cash and 2.14 million in debt, giving a net cash position of 8.68 million.

Cash & Cash Equivalents 10.82M
Total Debt 2.14M
Net Cash 8.68M
Net Cash Per Share n/a
Equity (Book Value) 12.02M
Book Value Per Share 0.00
Working Capital 10.80M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -4.95 million and capital expenditures -24,927, giving a free cash flow of -4.98 million.

Operating Cash Flow -4.95M
Capital Expenditures -24,927
Free Cash Flow -4.98M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -279.70% and -268.37%.

Gross Margin 100.00%
Operating Margin -279.70%
Pretax Margin -268.37%
Profit Margin -268.37%
EBITDA Margin -273.48%
EBIT Margin -279.70%
FCF Margin n/a

Dividends & Yields

ATGGF does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -37.04%
Shareholder Yield n/a
Earnings Yield -16.98%
FCF Yield -8.75%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

ATGGF has an Altman Z-Score of 3.03 and a Piotroski F-Score of 1.

Altman Z-Score 3.03
Piotroski F-Score 1